Filter by
Found 1 from your keywords: author=Sampeliling, A.
The Benefit of Acarbose in NIDDM Patients with Secondary Failure to Glibencla…
Arround 10 percent NIDDM patients will develope secondary failure every year. Acarbose could lower the absorbtion of glucose from the intestines. The aim of the study is to evaluate the benefit of acorbose as adjuvant treatment to NIDDM with secondary failure to glibenclamide. Patients were secondary failure to glibenclamide include to the study. The study was done in two phases. First phase: t…
- Edition
- -
- ISBN/ISSN
- -
- Collation
- -
- Series Title
- -
- Call Number
- Majalah Kedokteran Indonesia,46(9)1996:484-488
Computer Science, Information & General Works 
Philosophy & Psychology 
Religion 
Social Sciences 
Language 
Pure Science 
Applied Sciences 
Art & Recreation 
Literature 
History & Geography